| 1 |
cell-free DNA
(2503 times)
|
Neoplasms
(679 times)
|
ctDNA (224 times)
NGS (208 times)
NSCLC (167 times)
|
2005 Circulation DNA: biological implications for cancer metastasis and immunology.
|
| 2 |
circulating free DNA
(174 times)
|
Neoplasms
(83 times)
|
ctDNA (34 times)
CTCs (24 times)
NSCLC (24 times)
|
2008 Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.
|
| 3 |
cell-free deoxyribonucleic acid
(22 times)
|
Neoplasms
(3 times)
|
CTCs (2 times)
NETs (2 times)
TG (2 times)
|
2012 Cell-free DNA as a measure of transplant injury.
|
| 4 |
cell-free fetal DNA
(20 times)
|
Obstetrics
(9 times)
|
NT (3 times)
ASHG (1 time)
BORN (1 time)
|
2015 Noninvasive Digital Detection of Fetal DNA in Plasma of 4-Week-Pregnant Women following In Vitro Fertilization and Embryo Transfer.
|
| 5 |
cell-free plasma DNA
(14 times)
|
Neoplasms
(6 times)
|
EGFR (4 times)
NGS (3 times)
ddPCR (2 times)
|
2009 Cell-free plasma DNA during Hemodialysis.
|
| 6 |
cell-free tumor DNA
(12 times)
|
Neoplasms
(4 times)
|
CL (1 time)
CNV (1 time)
CT (1 time)
|
2015 Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
|
| 7 |
cell-free circulating tumor DNA
(11 times)
|
Neoplasms
(8 times)
|
NGS (4 times)
aNSCLC (2 times)
OS (2 times)
|
2016 Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.
|
| 8 |
cell-free nucleic acids
(6 times)
|
Biochemistry
(1 time)
|
AT (1 time)
CAP (1 time)
cCR (1 time)
|
2020 [Guiding significance of pathological diagnosis in watch and wait strategy for locally advanced rectal cancer patients after neoadjuvant therapy].
|
| 9 |
circulating free tumor DNA
(4 times)
|
Neoplasms
(3 times)
|
EGFR (2 times)
NSCLC (2 times)
exoNA (1 time)
|
2016 New Strategies in Metastatic Hormone Receptor-Positive Breast Cancer: Searching for Biomarkers to Tailor Endocrine and Other Targeted Therapies.
|
| 10 |
cell-free DNA screening
(3 times)
|
Obstetrics
(2 times)
|
DSD (1 time)
SCA (1 time)
|
2019 The personal utility of cfDNA screening: Pregnant patients' experiences with cfDNA screening and views on expanded cfDNA panels.
|
| 11 |
circulating fetal DNA
(3 times)
|
Social Medicine
(1 time)
|
LOD (2 times)
GE (1 time)
LOQ (1 time)
|
2005 Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma.
|
| 12 |
cell-free DNA analysis
(2 times)
|
Gynecology
(1 time)
|
ctDNA (1 time)
|
2022 Antenatal screening for chromosomal abnormalities.
|
| 13 |
cell-free DNA concentration
(2 times)
|
Jurisprudence
(1 time)
|
CTCs (1 time)
ctKRAS (1 time)
LAPC (1 time)
|
2020 Biological variability of cell-free DNA in healthy females at rest within a short time course.
|
| 14 |
cell-free DNA levels
(2 times)
|
Science
(1 time)
|
BPH (1 time)
PC (1 time)
|
2008 Effect of cell-free DNA of patients with cardiomyopathy and rDNA on the frequency of contraction of electrically paced neonatal rat ventricular myocytes in culture.
|
| 15 |
circulating free plasma DNA
(2 times)
|
Genetics, Medical
(1 time)
|
NF1 (1 time)
PNF (1 time)
|
2021 Circulating free DNA in the plasma of individuals with neurofibromatosis type 1.
|
| 16 |
circulating-free-deoxyribonucleic-acid
(2 times)
|
Neoplasms
(2 times)
|
cCR (1 time)
DFA (1 time)
LARC (1 time)
|
2020 Measurement of circulating free DNA in squamous cell carcinoma of the anus and relation to risk factors and recurrence.
|
| 17 |
cell free fetal DNA in maternal blood
(1 time)
|
Gynecology
(1 time)
|
NIPT (1 time)
SNPs (1 time)
|
2016 [Clinical implementation of non-invasive prenatal study for detecting aneuploidies by fetal DNA based on single nucleotide polymorphisms: two years in Mexico].
|
| 18 |
cell-free DNA fragments
(1 time)
|
Hematology
(1 time)
|
---
|
2022 Controversies in the Interpretation of Liquid Biopsy Data in Lymphoma.
|
| 19 |
Cell-free DNA in blood
(1 time)
|
Medicine
(1 time)
|
AUC (1 time)
|
2012 Multiparametric analysis of cell-free DNA in melanoma patients.
|
| 20 |
cell-free DNA isolated with silica membrane-based
(1 time)
|
Vascular Diseases
(1 time)
|
FXII (1 time)
MPO (1 time)
NETs (1 time)
|
2021 Myeloperoxidase has no effect on the low procoagulant activity of silica-free DNA.
|
| 21 |
cell-free DNA testing
(1 time)
|
Obstetrics
(1 time)
|
NPV (1 time)
PPV (1 time)
SCA (1 time)
|
2023 A systematic review and meta-analysis of cell-free DNA testing for detection of fetal sex chromosome aneuploidy.
|
| 22 |
Cell-free DNA-based noninvasive prenatal testing
(1 time)
|
Genetics, Medical
(1 time)
|
HCPs (1 time)
NIPT (1 time)
|
2019 Understanding attitudes and behaviors towards cell-free DNA-based noninvasive prenatal testing (NIPT): A survey of European health-care providers.
|
| 23 |
cell-free fragments of DNA
(1 time)
|
Hematologic Diseases
(1 time)
|
circRNA (1 time)
DLBCL (1 time)
lncRNA (1 time)
|
2021 Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review.
|
| 24 |
cell-free genomic DNA
(1 time)
|
Veterinary Medicine
(1 time)
|
MHC (1 time)
|
2020 A novel technique for retrospective genetic analysis of the response to vaccination or infection using cell-free DNA from archived sheep serum and plasma.
|
| 25 |
cell-free methylated DNA
(1 time)
|
Gastrointestinal Diseases
(1 time)
|
RT (1 time)
|
2022 Cardiomyocyte-specific circulating cell-free methylated DNA in esophageal cancer patients treated with chemoradiation.
|
| 26 |
characterization.Cell-free DNA
(1 time)
|
|
DNA (1 time)
NGS (1 time)
PJI (1 time)
|
2021 Next generation sequencing for pathogen detection in periprosthetic joint infections.
|
| 27 |
circulating fetal DNA in maternal blood
(1 time)
|
Genital Diseases, Female
(1 time)
|
ART (1 time)
|
2018 [Cell-free fetal DNA analysis in maternal plasma as a screening test for trisomy 21 in twin pregnancies].
|
| 28 |
circulating free amylin DNA
(1 time)
|
Medicine
(1 time)
|
NOD (1 time)
qPCR (1 time)
T1D (1 time)
|
2016 Circulating Differentially Methylated Amylin DNA as a Biomarker of beta-Cell Loss in Type 1 Diabetes.
|
| 29 |
circulating free/fragments of tumor DNA
(1 time)
|
Pathology
(1 time)
|
CTCs (1 time)
|
2016 Application of Liquid Biopsy for Lung Cancer Treatment.
|
| 30 |
composition of extracellular free DNA
(1 time)
|
Biochemical Phenomena
(1 time)
|
---
|
2004 [Extracellular DNA fragments and DNAse activity in blood serum of rats with transplantated Guerin's carcinoma after multiple exposures to low doses of X-irradiation].
|
| 31 |
detect free DNA
(1 time)
|
Genetics, Medical
(1 time)
|
FISH (1 time)
NIPT (1 time)
SNP-array (1 time)
|
2021 [Non-invasive prenatal testing and genetic diagnosis of a case of Pallister-Killian syndrome].
|
| 32 |
extracellular free DNA
(1 time)
|
Pediatrics
(1 time)
|
AUC (1 time)
CAP (1 time)
CRP (1 time)
|
2019 [Significance of neutrophil extracellular trap and its markers in the early diagnosis of community-acquired pneumonia in children].
|
| 33 |
Graft-cell-free DNA
(1 time)
|
|
ds-cfDNA (1 time)
InDel (1 time)
ROC (1 time)
|
2023 Donor-Specific Cell-Free DNA qPCR Quantification as a Noninvasive Accurate Biomarker for Early Rejection Detection in Liver Transplantation.
|
A Search Service for Abbreviation / Long Form